Drug profile

The FDA adverse-event record for Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

147 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. See the species affected, top reactions, and outcomes below.

147
adverse-event reports
10.9%
death-coded share
Dog
most-reported species
42
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
147
Total Reports
16
Deaths Reported
10.9%
Death Rate

Active Ingredients

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

Administration Routes

SubcutaneousUnknownParenteral

Species Affected

Dog 147

Most Affected Breeds

Retriever - Labrador 12
Shepherd Dog - Australian 11
Retriever - Golden 8
Siberian Husky 7
Crossbred Canine/dog 7
Shih Tzu 5
Terrier - Jack Russell 5
Terrier - Yorkshire 4
Spitz - German Pomeranian 4
Shepherd Dog - German 4

Most Reported Reactions

Vomiting 42
Lethargy (see also Central nervous system depression in 'Neurological') 24
Other abnormal test result NOS 19
Diarrhoea 18
Not eating 14
Anaphylaxis 11
Anorexia 10
Pale mucous membrane 10
Lethargy (see also Central nervous system depression in Neurological) 10
Death by euthanasia 9
Injection site swelling 9
Hives (see also 'Skin') 9

Outcome Breakdown

Recovered/Normal
57 (38.8%)
Outcome Unknown
43 (29.3%)
Ongoing
31 (21.1%)
Euthanized
9 (6.1%)
Died
7 (4.8%)

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract Adverse Event Insights

147 reports name Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract; 16 recorded a death outcome (10.9% of reported events, not a population-level mortality rate). Active ingredient: Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. Administration routes: Subcutaneous, Unknown, Parenteral.

By species: Dog (147 reports). By breed: Retriever - Labrador (12), Shepherd Dog - Australian (11), Retriever - Golden (8).

Leading clinical signs: Vomiting (42), Lethargy (see also Central nervous system depression in 'Neurological') (24), Other abnormal test result NOS (19), Diarrhoea (18). Outcome, 147 coded reports: Recovered/Normal leads at 38.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.